326 related articles for article (PubMed ID: 17313560)
1. Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.
Gambero S; Canalli AA; Traina F; Albuquerque DM; Saad ST; Costa FF; Conran N
Eur J Haematol; 2007 Feb; 78(2):144-51. PubMed ID: 17313560
[TBL] [Abstract][Full Text] [Related]
2. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
Odièvre MH; Bony V; Benkerrou M; Lapouméroulie C; Alberti C; Ducrocq R; Jacqz-Aigrain E; Elion J; Cartron JP
Haematologica; 2008 Apr; 93(4):502-10. PubMed ID: 18322255
[TBL] [Abstract][Full Text] [Related]
3. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea.
Cartron JP; Elion J
Transfus Clin Biol; 2008; 15(1-2):39-50. PubMed ID: 18515167
[TBL] [Abstract][Full Text] [Related]
4. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells.
Brun M; Bourdoulous S; Couraud PO; Elion J; Krishnamoorthy R; Lapoumeroulie C
Pharmacogenomics J; 2003; 3(4):215-26. PubMed ID: 12931135
[TBL] [Abstract][Full Text] [Related]
6. Role of Lu/BCAM in abnormal adhesion of sickle red blood cells to vascular endothelium.
El Nemer W; Gauthier E; Wautier MP; Rahuel C; Gane P; Galactéros F; Wautier JL; Cartron JP; Colin Y; Le Van Kim C
Transfus Clin Biol; 2008; 15(1-2):29-33. PubMed ID: 18514010
[TBL] [Abstract][Full Text] [Related]
7. Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation.
Canalli AA; Franco-Penteado CF; Saad ST; Conran N; Costa FF
Haematologica; 2008 Apr; 93(4):605-9. PubMed ID: 18326523
[TBL] [Abstract][Full Text] [Related]
8. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients.
Pallis FR; Conran N; Fertrin KY; Olalla Saad ST; Costa FF; Franco-Penteado CF
Br J Haematol; 2014 Jan; 164(2):286-95. PubMed ID: 24383847
[TBL] [Abstract][Full Text] [Related]
9. Increased adhesive properties of eosinophils in sickle cell disease.
Canalli AA; Conran N; Fattori A; Saad ST; Costa FF
Exp Hematol; 2004 Aug; 32(8):728-34. PubMed ID: 15308324
[TBL] [Abstract][Full Text] [Related]
10. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea.
Styles LA; Lubin B; Vichinsky E; Lawrence S; Hua M; Test S; Kuypers F
Blood; 1997 Apr; 89(7):2554-9. PubMed ID: 9116302
[TBL] [Abstract][Full Text] [Related]
11. Identification of differentially expressed genes induced by hydroxyurea in reticulocytes from sickle cell anaemia patients.
Moreira LS; de Andrade TG; Albuquerque DM; Cunha AF; Fattori A; Saad ST; Costa FF
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):651-5. PubMed ID: 18215186
[TBL] [Abstract][Full Text] [Related]
12. B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease.
Zen Q; Batchvarova M; Twyman CA; Eyler CE; Qiu H; De Castro LM; Telen MJ
Am J Hematol; 2004 Feb; 75(2):63-72. PubMed ID: 14755370
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
Conran N; Fattori A; Saad ST; Costa FF
Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
[TBL] [Abstract][Full Text] [Related]
15. Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin.
Assis A; Conran N; Canalli AA; Lorand-Metze I; Saad ST; Costa FF
Acta Haematol; 2005; 113(2):130-6. PubMed ID: 15802892
[TBL] [Abstract][Full Text] [Related]
16. Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation.
Chaar V; Laurance S; Lapoumeroulie C; Cochet S; De Grandis M; Colin Y; Elion J; Le Van Kim C; El Nemer W
J Biol Chem; 2014 Apr; 289(16):11512-11521. PubMed ID: 24616094
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.
Noborio-Hatano K; Kikuchi J; Takatoku M; Shimizu R; Wada T; Ueda M; Nobuyoshi M; Oh I; Sato K; Suzuki T; Ozaki K; Mori M; Nagai T; Muroi K; Kano Y; Furukawa Y; Ozawa K
Oncogene; 2009 Jan; 28(2):231-42. PubMed ID: 18850009
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
Mahlknecht U; Schönbein C
Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory mediators promote strong sickle cell adherence to endothelium under venular flow conditions.
Walmet PS; Eckman JR; Wick TM
Am J Hematol; 2003 Aug; 73(4):215-24. PubMed ID: 12879422
[TBL] [Abstract][Full Text] [Related]
20. Activation state of alpha4beta1 integrin on sickle red blood cells is linked to the duffy antigen receptor for chemokines (DARC) expression.
Durpès MC; Hardy-Dessources MD; El Nemer W; Picot J; Lemonne N; Elion J; Decastel M
J Biol Chem; 2011 Jan; 286(4):3057-64. PubMed ID: 21088296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
